These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12115502)

  • 21. Loss of heterozygosity in chromosomal region 16q24.3 associated with progression of prostate cancer.
    Härkönen P; Kyllönen AP; Nordling S; Vihko P
    Prostate; 2005 Feb; 62(3):267-74. PubMed ID: 15389780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymph node metastasis is associated with allelic loss on chromosome 13q12-13 in esophageal squamous cell carcinoma.
    Harada H; Tanaka H; Shimada Y; Shinoda M; Imamura M; Ishizaki K
    Cancer Res; 1999 Aug; 59(15):3724-9. PubMed ID: 10446988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and mutational analysis of the MADR2/Smad2 gene in human prostate cancer.
    Latil A; Pesche S; Valéri A; Fournier G; Cussenot O; Lidereau R
    Prostate; 1999 Sep; 40(4):225-31. PubMed ID: 10420150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LAPSER1: a novel candidate tumor suppressor gene from 10q24.3.
    Cabeza-Arvelaiz Y; Thompson TC; Sepulveda JL; Chinault AC
    Oncogene; 2001 Oct; 20(46):6707-17. PubMed ID: 11709705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation in liver tissues and cell lines of the transcription of 13 genes mapping to the 16q24 region that are frequently deleted in hepatocellular carcinoma.
    Riou P; Saffroy R; Comoy J; Gross-Goupil M; Thiéry JP; Emile JF; Azoulay D; Piatier-Tonneau D; Lemoine A; Debuire B
    Clin Cancer Res; 2002 Oct; 8(10):3178-86. PubMed ID: 12374686
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allelic imbalance at 13q14.2 approximately q14.3 in localized prostate cancer is associated with early biochemical relapse.
    Brookman-Amissah N; Nariculam J; Freeman A; Willamson M; Kirby RS; Masters JR; Feneley MR
    Cancer Genet Cytogenet; 2007 Dec; 179(2):118-26. PubMed ID: 18036398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defining a common region of deletion at 13q21 in human cancers.
    Chen C; Brabham WW; Stultz BG; Frierson HF; Barrett JC; Sawyers CL; Isaacs JT; Dong JT
    Genes Chromosomes Cancer; 2001 Aug; 31(4):333-44. PubMed ID: 11433524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limiting the location of putative human prostate cancer tumor suppressor genes on chromosome 18q.
    Yin Z; Babaian RJ; Troncoso P; Strom SS; Spitz MR; Caudell JJ; Stein JD; Kagan J
    Oncogene; 2001 Apr; 20(18):2273-80. PubMed ID: 11402322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
    Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
    Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation of DICE1: a gene frequently affected by LOH and downregulated in lung carcinomas.
    Wieland I; Arden KC; Michels D; Klein-Hitpass L; Böhm M; Viars CS; Weidle UH
    Oncogene; 1999 Aug; 18(32):4530-7. PubMed ID: 10467397
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of 99 microdissected prostate carcinomas reveals a high frequency of allelic loss on chromosome 8p12-21.
    Vocke CD; Pozzatti RO; Bostwick DG; Florence CD; Jennings SB; Strup SE; Duray PH; Liotta LA; Emmert-Buck MR; Linehan WM
    Cancer Res; 1996 May; 56(10):2411-6. PubMed ID: 8625320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of heterozygosity on chromosome 13 is associated with advanced stage prostate cancer.
    Afonso A; Emmert-Buck MR; Duray PH; Bostwick DG; Linehan WM; Vocke CD
    J Urol; 1999 Sep; 162(3 Pt 1):922-6. PubMed ID: 10458409
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
    Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
    Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lack of somatic mutation in the coding sequence of SIAH1 in tumors hemizygous for this candidate tumor suppressor gene.
    Medhioub M; Vaury C; Hamelin R; Thomas G
    Int J Cancer; 2000 Sep; 87(6):794-7. PubMed ID: 10956387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13.
    Fiedler U; Ehlers W; Meye A; Füssel S; Faller G; Schmidt U; Wirth MP
    Anticancer Res; 2001; 21(4A):2341-50. PubMed ID: 11724291
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular analysis of WFDC1/ps20 gene in prostate cancer.
    Watson JE; Kamkar S; James K; Kowbel D; Andaya A; Paris PL; Simko J; Carroll P; McAlhany S; Rowley D; Collins C
    Prostate; 2004 Oct; 61(2):192-9. PubMed ID: 15305342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of heterozygosity on chromosome 2 in Japanese patients with prostate cancer.
    Ueda T; Komiya A; Suzuki H; Shimbo M; Sakamoto S; Imamoto T; Akakura K; Shiraishi T; Ichikawa T
    Prostate; 2005 Aug; 64(3):265-71. PubMed ID: 15717310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of heterozygosity at 7q31 is a frequent and early event in prostate cancer.
    Latil A; Cussenot O; Fournier G; Baron JC; Lidereau R
    Clin Cancer Res; 1995 Nov; 1(11):1385-9. PubMed ID: 9815935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining the region(s) of deletion at 6q16-q22 in human prostate cancer.
    Hyytinen ER; Saadut R; Chen C; Paull L; Koivisto PA; Vessella RL; Frierson HF; Dong JT
    Genes Chromosomes Cancer; 2002 Jul; 34(3):306-12. PubMed ID: 12007191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.